  Synergies of microtissue design, viral transduction and adjustable transgene expression for regenerative medicine  
Recent advances in tissue engineering, gene therapy, gene-function analysis, animal-free drug testing, drug discovery, biopharmaceutical manufacturing and cell-phenotype engineering have capitalized on a core technology portfolio including artificial microtissue design. 